CORAL Renal Trial To Show Risks, Benefits Of Stenting Over Drugs
This article was originally published in The Gray Sheet
Executive Summary
The Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial likely will provide the first definitive evidence on the benefits of renal stenting, according to Julio Palmaz, MD, University of Texas
You may also be interested in...
Stenting Renal Arteries Sounds Good In Theory But Evidence Not There – AHRQ
Despite the increased use of stents to treat renal artery stenosis, there is little evidence to support revasculari-zation's superiority over medical management, according to a draft review by the Agency for Healthcare Research & Quality
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.